Mimedx (MDXG) Total Current Liabilities (2010 - 2026)

Mimedx has disclosed Total Current Liabilities across 17 years of filings, most recently posting $44.6 million for Q1 2026.

• Total Current Liabilities for Q1 2026 came in at $44.6 million, up 4.53% year-over-year; the trailing twelve-month figure through Mar 2026 was $44.6 million (up 4.53% YoY), and the FY2025 annual result was $64.3 million, up 40.95% from the prior year.
• Total Current Liabilities came in at $44.6 million for Q1 2026 at Mimedx, down from $64.3 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $64.3 million in Q4 2025 to a low of $36.6 million in Q1 2022.
• The 5-year median for Total Current Liabilities is $43.6 million (2023), against an average of $45.1 million.
• Across the five-year window, Total Current Liabilities tumbled 33.96% in 2022 and surged 40.95% in 2025, its largest moves.
• Mimedx's Total Current Liabilities stood at $43.6 million in 2022, then gained by 5.63% to $46.0 million in 2023, then decreased by 0.9% to $45.6 million in 2024, then soared by 40.95% to $64.3 million in 2025, then slumped by 30.68% to $44.6 million in 2026.
• The last three Total Current Liabilities figures came in at $44.6 million (Q1 2026), $64.3 million (Q4 2025), and $57.7 million (Q3 2025), per Business Quant data.